Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 8/20 | 0.36 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | OXTR | P30559 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11291088 | 1.00 | NAAA (0.36) | NAAAASAH1ALDH1A1CTSLCCR2 | |
| SCHEMBL10542453 | 1.00 | NAAA (0.36) | NAAAASAH1ALDH1A1CTSLCCR2 | |
| SCHEMBL10541610 | 0.86 | NAAA (0.37) | NAAAASAH1ALDH1A1CTSLOXTR | |
| SCHEMBL10546563 | 0.85 | NAAA (0.39) | NAAAASAH1ALDH1A1CTSLCCR2 | |
| SCHEMBL10544310 | 0.85 | ALDH1A1 (0.32) | ALDH1A1OXTR | |
| SCHEMBL10543252 | 0.80 | NAAA (0.40) | NAAAASAH1ALDH1A1CTSLCCR2 | |
| SCHEMBL11208661 | 0.79 | ALDH1A1 (0.37) | ALDH1A1OXTR | |
| SCHEMBL11290317 | 0.79 | ALDH1A1 (0.37) | ALDH1A1OXTR | |
| SCHEMBL11208658 | 0.79 | ALDH1A1 (0.37) | ALDH1A1OXTR | |
| SCHEMBL10544136 | 0.78 | MAPT (0.38) | NAAAALDH1A1CTSLOXTRCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0050965-A1 | Beta-lactamase inhibitory composition | Takeda Chemical Industries, Ltd. (JP) | 1982-05-05 | — | — | EP | disclosed |